selinexor,ruxolitinib
incyte,novartis,karyopharm therapeutics
['xport,mf,034', 'xport,mf,34']
welcome #asco23 attendees! we will have a couple of poster presentations on monday, june 5th. come join us as we share updated results from xport-mf-034. look forward to seeing you! 
Karyopharm Therapeutics Inc. is an oncology-focused biopharmaceutical company focused on the discovery, development and commercialization of novel medicines.